-
1
-
-
0035942767
-
Medical treatment of peripheral arterial disease and claudication
-
Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 2001;344:1608-1621.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1608-1621
-
-
Hiatt, W.R.1
-
2
-
-
0034712521
-
ABC of arterial and venous disease: Chronic lower limb ischemia
-
Beard JD. ABC of arterial and venous disease: chronic lower limb ischemia. B.M.J. 2000;320:854-857.
-
(2000)
B.M.J.
, vol.320
, pp. 854-857
-
-
Beard, J.D.1
-
3
-
-
0034076189
-
Mechanisms of angiogenesis and arteriogenesis
-
Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000;6:389-395.
-
(2000)
Nat. Med.
, vol.6
, pp. 389-395
-
-
Carmeliet, P.1
-
4
-
-
0029974130
-
Molecular mechanisms of coronary collateral vessel growth
-
Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ. Res. 1996;79:911-919.
-
(1996)
Circ. Res.
, vol.79
, pp. 911-919
-
-
Schaper, W.1
Ito, W.D.2
-
5
-
-
19144371999
-
Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
-
Isner JM, Walsh K, Symes J, et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 1996;7:959-988.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 959-988
-
-
Isner, J.M.1
Walsh, K.2
Symes, J.3
-
6
-
-
0029975133
-
Therapeutic angiogenesis: A new frontier for vascular therapy
-
Isner JM. Therapeutic angiogenesis: a new frontier for vascular therapy. Vasc. Med. 1996;1:79-87.
-
(1996)
Vasc. Med.
, vol.1
, pp. 79-87
-
-
Isner, J.M.1
-
7
-
-
0030928619
-
Gene therapy: Promises, problems and prospects
-
Verma IM, Somia N. Gene therapy: promises, problems and prospects. Nature 1997;389:239-242.
-
(1997)
Nature
, vol.389
, pp. 239-242
-
-
Verma, I.M.1
Somia, N.2
-
8
-
-
0030453791
-
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
-
Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996;94:3281-3290.
-
(1996)
Circulation
, vol.94
, pp. 3281-3290
-
-
Tsurumi, Y.1
Takeshita, S.2
Chen, D.3
-
9
-
-
0033619428
-
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre randomised, controlled trial
-
Mann MJ, Whittemore AD, Donaldson MC, et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre randomised, controlled trial. Lancet 1999;354:1493-1498.
-
(1999)
Lancet
, vol.354
, pp. 1493-1498
-
-
Mann, M.J.1
Whittemore, A.D.2
Donaldson, M.C.3
-
10
-
-
0028344109
-
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
-
Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 1994;93:662-670.
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 662-670
-
-
Takeshita, S.1
Zheng, L.P.2
Brogi, E.3
-
11
-
-
0027999815
-
Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb
-
Bauters C, Asahara T, Zheng LP, et al. Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 1994;267:H1263-H1271.
-
(1994)
Am. J. Physiol.
, vol.267
-
-
Bauters, C.1
Asahara, T.2
Zheng, L.P.3
-
12
-
-
0026761584
-
Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
-
Baffour R, Berman J, Garb JL, et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 1992;16:181-191.
-
(1992)
J. Vasc. Surg.
, vol.16
, pp. 181-191
-
-
Baffour, R.1
Berman, J.2
Garb, J.L.3
-
13
-
-
0030854050
-
Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin
-
Rosengart TK, Budenbender KT, Duenas M, et al. Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. J. Vasc. Surg. 1997;26:302-312.
-
(1997)
J. Vasc. Surg.
, vol.26
, pp. 302-312
-
-
Rosengart, T.K.1
Budenbender, K.T.2
Duenas, M.3
-
14
-
-
0028827625
-
Synergistic effect of vascular endothelial growth factor and basic growth factor on angiogenesis in vivo
-
Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic growth factor on angiogenesis in vivo. Circulation 1995;92(Suppl II):365-371.
-
(1995)
Circulation
, vol.92
, Issue.2 SUPPL.
, pp. 365-371
-
-
Asahara, T.1
Bauters, C.2
Zheng, L.P.3
-
15
-
-
0033820196
-
Basic fibroblast growth factor in patients with intermittent claudication: Results of a phase I trial
-
Lazarous DF, Unger EF, Epstein SE, et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J. Am. Coll. Cardiol. 2000;36:1239-1244.
-
(2000)
J. Am. Coll. Cardiol.
, vol.36
, pp. 1239-1244
-
-
Lazarous, D.F.1
Unger, E.F.2
Epstein, S.E.3
-
16
-
-
0037097035
-
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): A randomised trial
-
Lederman RJ, Mendelsohn FO, Anderson RD, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 2002;359:2053-2058.
-
(2002)
Lancet
, vol.359
, pp. 2053-2058
-
-
Lederman, R.J.1
Mendelsohn, F.O.2
Anderson, R.D.3
-
17
-
-
0032979424
-
Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy
-
Morishita R, Nakamura S, Hayashi S, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999;33:1379-1384.
-
(1999)
Hypertension
, vol.33
, pp. 1379-1384
-
-
Morishita, R.1
Nakamura, S.2
Hayashi, S.3
-
18
-
-
0032102292
-
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
-
Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 1998;101:2567-2578.
-
(1998)
J. Clin. Invest.
, vol.101
, pp. 2567-2578
-
-
Murohara, T.1
Asahara, T.2
Silver, M.3
-
19
-
-
0034665268
-
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb
-
Silvestre JS, Mallat Z, Duriez M, et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 2000;87:448-452.
-
(2000)
Circ. Res.
, vol.87
, pp. 448-452
-
-
Silvestre, J.S.1
Mallat, Z.2
Duriez, M.3
-
20
-
-
0037032006
-
Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb
-
Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, et al. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ. Res. 2002;91:441-448.
-
(2002)
Circ. Res.
, vol.91
, pp. 441-448
-
-
Mallat, Z.1
Silvestre, J.S.2
Le Ricousse-Roussanne, S.3
-
21
-
-
0026081739
-
Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
-
Le Noble FA, Hekking JW, van Straaten HW, et al. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur. J. Pharmacol. 1991;195:305-306.
-
(1991)
Eur. J. Pharmacol.
, vol.195
, pp. 305-306
-
-
Le Noble, F.A.1
Hekking, J.W.2
Van Straaten, H.W.3
-
22
-
-
0027537010
-
Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane
-
Le Noble FA, Schreurs NH, van Straaten HW, et al. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol. 1993;264:460-465.
-
(1993)
Am. J. Physiol.
, vol.264
, pp. 460-465
-
-
Le Noble, F.A.1
Schreurs, N.H.2
Van Straaten, H.W.3
-
23
-
-
0030997520
-
Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma
-
Walsh DA, Hu DE, Wharton J, et al. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br. J. Pharmacol. 1997;120:1302-1311.
-
(1997)
Br. J. Pharmacol.
, vol.120
, pp. 1302-1311
-
-
Walsh, D.A.1
Hu, D.E.2
Wharton, J.3
-
24
-
-
0030638718
-
Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats
-
Gohlke P, Kuwer I, Schnell A, et al. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1997;29:478-482.
-
(1997)
Hypertension
, vol.29
, pp. 478-482
-
-
Gohlke, P.1
Kuwer, I.2
Schnell, A.3
-
25
-
-
0033564447
-
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
-
Fahre JE, Rivard A, Magner M, et al. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999;99:3043-3049.
-
(1999)
Circulation
, vol.99
, pp. 3043-3049
-
-
Fahre, J.E.1
Rivard, A.2
Magner, M.3
-
26
-
-
0035851219
-
Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway
-
Silvestre JS, Bergaya S, Tamarat R, et al. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ. Res. 2001;89:678-683.
-
(2001)
Circ. Res.
, vol.89
, pp. 678-683
-
-
Silvestre, J.S.1
Bergaya, S.2
Tamarat, R.3
-
27
-
-
0029958320
-
Gene transfert of naked DNA encoding for three isoforms, of vascular endothelial growth factor stimulates collateral development in vivo
-
Takeshita S, Tsurumi Y, Couffinhal T, et al. Gene transfert of naked DNA encoding for three isoforms, of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 1996;75:487-501.
-
(1996)
Lab. Invest.
, vol.75
, pp. 487-501
-
-
Takeshita, S.1
Tsurumi, Y.2
Couffinhal, T.3
-
28
-
-
0028344109
-
Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model
-
Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 1994;93:662-670.
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 662-670
-
-
Takeshita, S.1
Zheng, L.P.2
Brogi, E.3
-
29
-
-
0030583587
-
Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia
-
Takeshita S, Weir L, Chen D, et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 1996;227:628-635.
-
(1996)
Biochem. Biophys. Res. Commun.
, vol.227
, pp. 628-635
-
-
Takeshita, S.1
Weir, L.2
Chen, D.3
-
30
-
-
0032965317
-
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
-
Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 1999;154:355-363.
-
(1999)
Am. J. Pathol.
, vol.154
, pp. 355-363
-
-
Rivard, A.1
Silver, M.2
Chen, D.3
-
31
-
-
0033594920
-
Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice
-
Couffinhal T, Silver M, Kearney M, et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 1999;99:3188-3198.
-
(1999)
Circulation
, vol.99
, pp. 3188-3198
-
-
Couffinhal, T.1
Silver, M.2
Kearney, M.3
-
32
-
-
0032583951
-
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
-
Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97:1114-1123.
-
(1998)
Circulation
, vol.97
, pp. 1114-1123
-
-
Baumgartner, I.1
Pieczek, A.2
Manor, O.3
-
33
-
-
0037313811
-
Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia
-
Shyu KG, Chang H, Wang BW, et al. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am. J. Med. 2003;114:85-92.
-
(2003)
Am. J. Med.
, vol.114
, pp. 85-92
-
-
Shyu, K.G.1
Chang, H.2
Wang, B.W.3
-
34
-
-
0034978983
-
Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia
-
Ohara N, Koyama H, Miyata T, et al. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther. 2001;8:837-845.
-
(2001)
Gene Ther.
, vol.8
, pp. 837-845
-
-
Ohara, N.1
Koyama, H.2
Miyata, T.3
-
35
-
-
0027031422
-
Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization
-
Nabel EG, Gordon D, Yang ZY, et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum. Gene Ther. 1992;3:649-656.
-
(1992)
Hum. Gene Ther.
, vol.3
, pp. 649-656
-
-
Nabel, E.G.1
Gordon, D.2
Yang, Z.Y.3
-
36
-
-
0035980172
-
Assessment of risks associated with cardiovascular gene therapy in human subjects
-
Isner JM, Vale PR, Symes JF, et al. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ. Res. 2001;89:389-400.
-
(2001)
Circ. Res.
, vol.89
, pp. 389-400
-
-
Isner, J.M.1
Vale, P.R.2
Symes, J.F.3
-
37
-
-
0037133624
-
Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris
-
Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002;105:1291-1297.
-
(2002)
Circulation
, vol.105
, pp. 1291-1297
-
-
Grines, C.L.1
Watkins, M.W.2
Helmer, G.3
|